New hope in treating cancer
Last month, Silicon Valley entrepreneur and philanthropist Sean Parker announced the launch of the new Parker Institute for Cancer Immunotherapy, a multi-institution effort established with a $250 million grant from his foundation. Stanford Medicine will be one of the institute’s six university-based research centers that will use the grant to advance the field of cancer immunotherapy. In this podcast, Crystal Mackall, MD, associate director of the Stanford Cancer Institute and co-medical director of the Stanford Laboratory for Cell and Gene Medicine, discusses the efforts here at Stanford.
Photo by Paul Keitz